Wolverine Trading’s Acceleron Pharma XLRN Stock Holding History

Wolverine Trading’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,400	Closed	-$1.38M	–	7079
2021 Q1	$1.38M	Buy	10,400 +7,200	+225%	+$930K	﹤0.01%	2336
2020 Q4	$409K	Sell	3,200 -1,100	-26%	-$129K	﹤0.01%	3398
2020 Q3	$486K	Sell	4,300 -2,500	-37%	-$249K	﹤0.01%	2863
2020 Q2	$654K	Buy	+6,800	New	+$655K	﹤0.01%	2440
2020 Q1	–	Sell	-7,700	Closed	-$405K	–	5582
2019 Q4	$405K	Sell	7,700 -1,700	-18%	-$77.5K	﹤0.01%	3270
2019 Q3	$380K	Buy	9,400 +1,500	+19%	+$65.1K	﹤0.01%	2924
2019 Q2	$325K	Sell	7,900 -4,100	-34%	-$170K	﹤0.01%	3185
2019 Q1	$559K	Buy	+12,000	New	+$527K	﹤0.01%	2647
2018 Q4	–	Sell	-6,700	Closed	-$383K	–	5671
2018 Q3	$383K	Buy	+6,700	New	+$329K	﹤0.01%	3436

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Wolverine Trading's XLRN Position: Q3 2021 in Review

Wolverine Trading sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 1,606 shares — an estimated $200K sold.

Wolverine Trading first reported a position in XLRN in Q3 2018 and held it in 3 quarters. The position peaked at $1.02M in Q3 2018. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

Wolverine Trading reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
Wolverine Trading sold 1,606 Acceleron Pharma shares in Q3 2021, an estimated $200K.
Wolverine Trading first reported a position in Acceleron Pharma in Q3 2018 and held it in 3 quarters.
Wolverine Trading's Acceleron Pharma position peaked at $1.02M in Q3 2018.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.